Tag: Dr. Bill Lombardi

Protected PCI: Current Data and Best Practices in High-Risk Patients

In this roundtable discussion, Dr. John Lasala of Washington University in St. Louis interviews Dr. Bill O’Neill (Henry Ford Hospital, Detroit, MI), Dr. Bill Lombardi (University of Washington, Seattle, WA), and Dr. Jeff Moses (Columbia University, New York, NY) on the current data regarding high-risk patients undergoing Protected PCI. During this interview, Dr. Moses provides … Continue reading “Protected PCI: Current Data and Best Practices in High-Risk Patients”

The FDA’s Shock Indication for the Impella

The FDA recently granted Abiomed approval to expand Impella™ 2.5 PMA to treat patients suffering cardiogenic shock following acute myocardial infarction or cardiac surgery. So we are very excited to speak with Dr. Bill Lombardi of University of Washington about the shock indication for the Impella® Platform of Devices. (Tweet This)